
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Eplerenone, an aldosterone blocker, is more effective in reducing blood pressure in patients with, than without, metabolic syndrome
Hiromichi Suzuki, Hiroshi Shuto, Chizuru Shuto, et al.
Therapeutic Advances in Cardiovascular Disease (2012) Vol. 6, Iss. 4, pp. 141-147
Closed Access | Times Cited: 8
Hiromichi Suzuki, Hiroshi Shuto, Chizuru Shuto, et al.
Therapeutic Advances in Cardiovascular Disease (2012) Vol. 6, Iss. 4, pp. 141-147
Closed Access | Times Cited: 8
Showing 8 citing articles:
Mineralocorticoid receptor blockade suppresses dietary salt-induced ACEI/ARB-resistant albuminuria in non-diabetic hypertension: a sub-analysis of evaluate study
Mitsuhiro Nishimoto, Hiroshi Ohtsu, Takeshi Marumo, et al.
Hypertension Research (2019) Vol. 42, Iss. 4, pp. 514-521
Closed Access | Times Cited: 25
Mitsuhiro Nishimoto, Hiroshi Ohtsu, Takeshi Marumo, et al.
Hypertension Research (2019) Vol. 42, Iss. 4, pp. 514-521
Closed Access | Times Cited: 25
Effect of Selective Mineralocorticoid Receptor Blockade on Flow-Mediated Dilation and Insulin Resistance in Older Adults with Metabolic Syndrome
Moon‐Hyon Hwang, Jeung‐Ki Yoo, Meredith Luttrell, et al.
Metabolic Syndrome and Related Disorders (2015) Vol. 13, Iss. 8, pp. 356-361
Open Access | Times Cited: 13
Moon‐Hyon Hwang, Jeung‐Ki Yoo, Meredith Luttrell, et al.
Metabolic Syndrome and Related Disorders (2015) Vol. 13, Iss. 8, pp. 356-361
Open Access | Times Cited: 13
Eplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndrome
Yan Zhang, Wen Zheng, Yuli Liu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 4
Yan Zhang, Wen Zheng, Yuli Liu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 4
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients
Luigina Guasti, Giovanni Gaudio, Alessandro Lupi, et al.
Drug Design Development and Therapy (2017) Vol. Volume 11, pp. 2293-2300
Open Access | Times Cited: 4
Luigina Guasti, Giovanni Gaudio, Alessandro Lupi, et al.
Drug Design Development and Therapy (2017) Vol. Volume 11, pp. 2293-2300
Open Access | Times Cited: 4
Diuretics
Nisharahmed Kherada, Waddy Gonzalez, Clive Rosendorff
Side effects of drugs annual (2014), pp. 289-296
Closed Access | Times Cited: 1
Nisharahmed Kherada, Waddy Gonzalez, Clive Rosendorff
Side effects of drugs annual (2014), pp. 289-296
Closed Access | Times Cited: 1
Mineralocorticoid receptor blockade--a novel approach to fight hyperkalaemia in chronic kidney disease
Eberhard Ritz, B. Pitt
Clinical Kidney Journal (2013) Vol. 6, Iss. 5, pp. 464-468
Open Access | Times Cited: 1
Eberhard Ritz, B. Pitt
Clinical Kidney Journal (2013) Vol. 6, Iss. 5, pp. 464-468
Open Access | Times Cited: 1
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol
Bárbara Loures Peralva, Kelli Borges dos Santos, Marina Guedes Fraga Lopes, et al.
REVISTA CIÊNCIAS EM SAÚDE (2023) Vol. 13, Iss. 1, pp. 22-25
Open Access
Bárbara Loures Peralva, Kelli Borges dos Santos, Marina Guedes Fraga Lopes, et al.
REVISTA CIÊNCIAS EM SAÚDE (2023) Vol. 13, Iss. 1, pp. 22-25
Open Access
Efeito do tratamento para síndrome metabólica na albuminúria: revisão sistemática e metanálise
Bárbara Loures Peralva
(2022)
Open Access
Bárbara Loures Peralva
(2022)
Open Access